Novo Nordisk (NVO): The GLP-1 Pioneer Under Siege — Can the Category Creator Defend Its Crown?
🤖 AI-SIMULATED BOARDROOM · NOT REAL STATEMENTS This is a fictional debate inspired by publicly known investment philosophies. All board member statements are AI simulations. THE BOARDROOM DEBATE — JULY 2026 The Company at a Glance Novo Nordisk A/S (NVO) is the Danish pharmaceutical giant that, alongside Eli Lilly, ignited the global GLP-1 revolution. Its […]